Transparency International Germany vs. Ratiopharm

الادعاءات

Ratiopharm, a pharmaceuticals company and major producer of generic drugs, has allegedly engaged in unethical marketing practices, including bribing doctors and pharmacists in Belgium, Canada, Spain, Estonia and Germany.

المبادئ التوجيهية ذات الصلة لمنظمة التعاون والتنمية في الميدان الاقتصادي

• Version 2000 Chapter III
• Version 2000 Chapter VI

النتيجة

In June 2006, the German NCP rejected the complaint citing the lack of transnational investment. Specifically, the NCP stated the complaint only dealt with alleged misbehaviour in Germany. In July 2006, Transparency International Germany resubmitted a revised and expanded complaint

تفاصيل إضافية

شكاوى أخرى

• Gresea & Transparency International Germany vs Ratiopharm
• Transparency International Germany vs. Ratiopharm

الأوراق

• ملف

  18 July 2006

  TI submits revised and expanded complaint (see: Transparency International - Germany vs. Ratiopharm refile).

  Transparency International Germany
• ملف

  20 April 2006

  Complaint submitted to German NCP.

  Transparency International Germany